OASDX Performance — Oakhurst Strategic Defined Risk Fund, Institutional Class
Data updated: 2026-03-30
OASDX returned +0.92% year to date and +10.32% over one year to Jan 2026. Annualised returns are +14.30% over 3 years and +8.87% over 5 years. Against its Market Neutral category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $149, against $137 for the category, and to $110 over one year, against $113. Volatility over the past three years was 7.84% a year. In the 12 months to Jan 2026 the fund lost a net $6.7M, and assets reached $72.26M.
OASDX Growth of $100
What $100 invested in Oakhurst Strategic Defined Risk Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Market Neutral category average over the same months.
| Period | OASDX | Category average |
|---|---|---|
| 1 year (Feb 2025 – Jan 2026) | $110 | $113 |
| 3 years (Feb 2023 – Jan 2026) | $149 | $137 |
| 5 years (Feb 2021 – Jan 2026) | $153 | $149 |
| Since data start (Feb 2020 – Jan 2026) | $165 | $157 |
OASDX Trailing Returns
Total returns to Jan 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +0.92% |
| 1 year | +10.32% |
| 3 years (annualised) | +14.30% |
| 5 years (annualised) | +8.87% |
OASDX Annual Returns
Calendar-year total returns of Oakhurst Strategic Defined Risk Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jan) | +0.92% |
| 2025 | +10.90% |
| 2024 | +18.06% |
| 2023 | +17.18% |
| 2022 | −13.43% |
| 2021 | +12.98% |
| 2020 (Feb–Dec) | +9.09% |
OASDX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.9% | — | — | — | — | — | — | — | — | — | — | — |
| 2025 | +1.5% | −0.8% | −3.3% | −0.1% | +3.8% | +3.0% | +1.6% | +1.2% | +2.3% | +1.7% | −0.1% | −0.1% |
| 2024 | +1.2% | +3.4% | +2.1% | −2.6% | +3.6% | +2.5% | +0.8% | +1.5% | +1.5% | −0.5% | +4.6% | −1.2% |
| 2023 | +3.7% | −1.8% | +2.5% | +1.0% | +0.2% | +4.9% | +2.7% | −1.3% | −3.2% | −1.6% | +6.2% | +3.2% |
| 2022 | −4.3% | −2.4% | +3.2% | −6.8% | 0.0% | −4.2% | +5.2% | −2.4% | −6.1% | +4.3% | +3.8% | −3.6% |
| 2021 | −1.0% | +1.5% | +1.2% | +2.6% | +0.3% | +1.3% | +1.4% | +1.8% | −3.4% | +4.5% | −0.7% | +3.0% |
| 2020 | — | −3.3% | −6.0% | +5.2% | +2.8% | +0.5% | +3.1% | +3.5% | −2.6% | −1.7% | +6.1% | +2.0% |
OASDX Risk
Risk measures from monthly returns over Feb 2023 – Jan 2026.
- 3-year volatility (annualised): 7.84%
- 3-year Sharpe ratio: 1.25 (vs 4.5% risk-free rate)
- Best month: +6.19% (Nov 2023)
- Worst month: −3.30% (Mar 2025)
OASDX Fund Flows
Monthly money in and out of Oakhurst Strategic Defined Risk Fund, from SEC Form N-PORT.
- 12-month net flow: −$6.7M
- 12-month gross sales (incl. reinvestments): $7.9M
- Sales ÷ redemptions: 0.54×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jan 2026 | $34K | $486K | −$452K |
| Dec 2025 | $5.5M | $1.7M | $3.9M |
| Nov 2025 | $275K | $231K | $44K |
| Oct 2025 | $50K | $267K | −$217K |
| Sep 2025 | $795K | $76K | $718K |
| Aug 2025 | $0 | $1.2M | −$1.2M |
| Jul 2025 | $100K | $610K | −$510K |
| Jun 2025 | $902K | $738K | $164K |
| May 2025 | $0 | $786K | −$786K |
| Apr 2025 | $77K | $6.4M | −$6.4M |
| Mar 2025 | $25K | $1.3M | −$1.3M |
| Feb 2025 | $135K | $859K | −$724K |
OASDX Assets Under Management
Net assets of Oakhurst Strategic Defined Risk Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-01-31 | $72.26M |
| 2025-10-31 | $74.34M |
| 2025-07-31 | $71.28M |
| 2025-04-30 | $66.72M |
| 2025-01-31 | $78.47M |
| 2024-10-31 | $79.34M |
| 2024-07-31 | $83.33M |
| 2024-04-30 | $80.24M |
| 2024-01-31 | $80.66M |
| 2023-10-31 | $76.67M |
| 2023-07-31 | $82.77M |
| 2023-04-30 | $83.89M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.